Président du jury Rasschaert, Joanne
Promoteur Pirson, Isabelle
Publication Non publié, 2009-01-09
| Résumé : | SH2-containing inositol polyphosphate 5-phosphatases, SHIP2, has been established as a regulator of the insulin cascade, of cell adhesion and spreading, actin structures, remodelling and cytoskeletal organization. However, the molecular mechanisms underlying these processes still needed additional investigations. Among different regulatory mechanisms, protein-protein interaction play an essential role. To better understand the molecular mechanism of SHIP2 in signalling pathway as well as to reveal novel roles of SHIP2, a two-hybrid was performed to search for SHIP2 protein interactors. JNK-interacting protein 1 (JIP1) and intersectin 1 (ITSN1) were two of the newly identified protein partners of SHIP2. In this thesis, we characterized the associations of SHIP2 with JIP1 and ITSN1 in different aspects as identifying the interacting domain involved, biochemical function regulations and cellular biological roles. The JIP scaffold family of proteins associate with MAPK, MAPKK and MAPKKK creating functional signaling modules to control the specificity of signal transduction. JIP1 is characterized as a scaffold protein assembling JNK, MAPK kinase 7 (MKK7), mixed lineage kinase (MLK), dual leucine zipper-bearing kinase (DLK). It thus enhances the selectivity and effectiveness of kinase activation during JNK signaling. In this thesis, the SHIP2-JIP1 interaction has been confirmed both in overexpression system in COS-7 and CHO-IR cells, and in native cells of COS-7. Both the proline-rich (PR) domain (residues 359-487) and PTB domain of JIP1 participated in this interaction. Overexpression of SHIP2 in COS-7 cells up-regulated JIP1-mediated JNK activation and the tyrosine phosphorylations of both JIP1 and MLK3. These effects were independent of SHIP2 catalytic activity. By the use of kinase inhibitors, we showed that Abl and Src family tyrosine kinases might be implicated in the regulation of JIP1 tyrosine phosphorylation. The residue Y270 of JIP1, a potential target of Abl tyrosine kinase, was shown to be involved in SHIP2-increased JIP1 tyrosine phosphorylation. In an in vitro assay, JIP1 negatively regulated the catalytic activity of SHIP2. In addition, upon the stimulation of okadaic acid, the overexpression of SHIP2 caused less viability of COS-7 cells. These data provide a new molecular link between SHIP2 and JIP1-mediated JNK pathway, and may help explain the biochemical mechanisms of SHIP2 in cellular apoptosis, as well as in insulin pathway.
Another protein partner, ITSN1, is a multi-domain protein which plays a role in endocytosis, MAPK signalling and actin cytoskeleton. The interaction between SHIP2 and ITSN1 was confirmed in overexpression systems in COS-7 cells, as well as at the physiological concentration with the endogenously expressed proteins in C2C12 and COS-7 cells. EGF stimulation did not modulate the association of SHIP2 and ITSN1. ITSN1-SH3D, A, C and E domains interacted with the C-terminal part of SHIP2 with the binding affinity as SH3D>SH3A>SH3C>SH3E. Upon the stimulation of EGF, the expression of SHIP2 may recruit ITSN1 short form (ITSN1-S) to cell membrane. The ITSN-mediated ERK1/2 and JNK activations in response to EGF were not modulated when SHIP2 or catalytic mutant of SHIP2 or TSHIP2 was overexpressed. The link between SHIP2 and ITSN may provide one of the molecular mechanisms used by SHIP2 to participate in receptor endocytosis regulation. In conclusion, our data of the associations of SHIP2 with JIP1 and ITSN1 provide evidence for potential novel biochemical mechanisms of SHIP2 to be implicated in JNK pathway as well as EGF receptor endocytosis. JIP1 and ITSN1, which are both implicated in the JNK pathway, may also have a link through the common protein partner SHIP2, giving rise to potential interesting study goal. |
